2022 Annual Meeting | Panel—Industry Perspective
Program Materials Program Evaluations
01:00 PM - 02:00 PM PDT | Speaker |
Panel - Industry Perspective
Logan D. Schneider, MD, Puja Aggarwal, MD, Michael J. Howell, MD, FAAN, Shawniqua Williams Roberson, MD |
Michael J. Howell, MD, FAAN | Dr. Howell has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for GEM Health. Dr. Howell has stock in Sleep Performance Institute. The institution of Dr. Howell has received research support from National Institutes of Health. Dr. Howell has received publishing royalties from a publication relating to health care. |
Shawniqua Williams Roberson, MD | Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. The institution of Dr. Williams Roberson has received research support from the National Institute on Aging. The institution of Dr. Williams Roberson has received research support from Brain & Behavior Research Foundation. Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Reviewer with the National Institutes of Health. Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Visiting Speaker with University of Pennsylvania. Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Faculty Speaker with the International Symposium for Intensive Care and Emergency Medicine. |
Puja Aggarwal, MD | Dr. Aggarwal has nothing to disclose. |
Logan D. Schneider, MD | Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care. |